Evolent Health Inc (EVH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Evolent Health Inc (EVH) has a cash flow conversion efficiency ratio of -0.002x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-984.00K) by net assets ($396.39 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Evolent Health Inc market cap and net worth for the company's overall valuation and market capitalisation.
Evolent Health Inc - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Evolent Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Evolent Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Evolent Health Inc ranked by their cash flow conversion efficiency. Explore Evolent Health Inc earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Entree Resources Ltd
TO:ETG
|
0.013x |
|
DIAMOND BIOFUND INC
TW:6901
|
-0.002x |
|
Guangdong Guanghong Holdings Co Ltd
SHE:000529
|
-0.001x |
|
Jinsanjiang (Zhaoqing) Silicon Material Company Limited
SHE:301059
|
N/A |
|
Eurocharm Holdings Co Ltd
TW:5288
|
0.027x |
|
CoAsia Microelectronics
TWO:8096
|
-1.653x |
|
Shenzhen TVT Digital Technology Co Ltd
SHE:002835
|
0.032x |
|
Hangzhou Wensli Silk Culture Co. Ltd.
SHE:301066
|
N/A |
Annual Cash Flow Conversion Efficiency for Evolent Health Inc (2012–2025)
The table below shows the annual cash flow conversion efficiency of Evolent Health Inc from 2012 to 2025. View EVH stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $415.19 Million | $38.84 Million | 0.094x | +399.18% |
| 2024-12-31 | $1.00 Billion | $18.77 Million | 0.019x | -85.97% |
| 2023-12-31 | $1.07 Billion | $142.58 Million | 0.134x | +1093.40% |
| 2022-12-31 | $859.42 Million | $-11.55 Million | -0.013x | -124.06% |
| 2021-12-31 | $693.63 Million | $38.75 Million | 0.056x | +313.32% |
| 2020-12-31 | $619.60 Million | $-16.23 Million | -0.026x | +42.95% |
| 2019-12-31 | $929.05 Million | $-42.65 Million | -0.046x | -164.36% |
| 2018-12-31 | $1.19 Billion | $-20.65 Million | -0.017x | +35.02% |
| 2017-12-31 | $1.05 Billion | $-27.96 Million | -0.027x | +31.36% |
| 2016-12-31 | $912.11 Million | $-35.51 Million | -0.039x | -83.49% |
| 2015-12-31 | $934.58 Million | $-19.83 Million | -0.021x | -100.06% |
| 2014-12-31 | $-2.07 Million | $-75.09 Million | 36.277x | +8363.21% |
| 2013-12-31 | $31.04 Million | $-13.63 Million | -0.439x | +82.12% |
| 2012-12-31 | $5.20 Million | $-12.77 Million | -2.455x | -- |
About Evolent Health Inc
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics an… Read more